| GC | Gastric Cancer |
| miR/microRNA | MicroRNA |
| lncRNA | Long non-coding RNA |
| mRNA | Messenger RNA |
| nt | Nucleotides |
| PDOs | Patient-derived organoids |
| NAT | Normal tissue adjacent to the tumor |
| EMT | Epithelial–mesenchymal transition |
| CRC | Colorectal cancer |
| HCC | Hepatocellular carcinoma |
| PAC | Pancreatic cancer |
| 3′-UTR | 3′ Untranslated Region |
| HER2 | Human epidermal growth factor receptor 2 |
| PD-L1 | Programmed death-ligand 1 |
| qRT-PCR/RT-PCR | Quantitative Real-Time Polymerase Chain Reaction |
| NC | Negative Control |
| RRR | Relative Response Ratio |
| MTS | 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2(4-sulfophenyl)-2H-tetrazolium |
| dsiRNA | Dicer-substrate siRNA |
| SD | Standard Deviation |
| ANOVA | Analysis of variance |
| TCGA-STAD | The Cancer Genome Atlas—Stomach Adenocarcinoma |
| ACCDiS | Advanced Center for Chronic Diseases |
| ICBM | Institute of Biomedical Sciences |
| CEMC | Center for Studies on Exercise, Metabolism and Cancer |
| HDSR | Hospital Dr. Sotero del Río |
| HHHA | Hospital Hernán Henríquez Aravena |
| TFBCH | Tumor and Fluid Bank, Hospital Clínico Universidad de Chile |
| dbGaP | Database of Genotypes and Phenotypes |
| KCNQ1OT1 | KCNQ1 opposite strand/antisense transcript 1 |
| RUNX1 | Runt-related transcription factor 1 |